Cargando…

Why is the presence of autoantibodies against GAD associated with a relatively slow progression to clinical diabetes?

Detalles Bibliográficos
Autores principales:	Ziegler, Anette-Gabriele, Bonifacio, Ezio
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2020
Materias:	Letter
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7351841/ https://www.ncbi.nlm.nih.gov/pubmed/32451571 http://dx.doi.org/10.1007/s00125-020-05175-8

Ejemplares similares

Autoantibodies to N-terminally truncated GAD improve clinical phenotyping of individuals with adult-onset diabetes: Action LADA 12
por: Achenbach, Peter, et al.
Publicado: (2018)

An Analysis of the Cross-Reactivity of Autoantibodies to GAD65 and GAD67 in Diabetes
por: Jayakrishnan, Bindu, et al.
Publicado: (2011)

Prevalence and Regional Distribution of Autoantibodies Against GAD65Ab in a European Population Without Diabetes: The EPIC-InterAct Study
por: Rolandsson, Olov, et al.
Publicado: (2015)

Decline in Titers of Anti-Idiotypic Antibodies Specific to Autoantibodies to GAD65 (GAD65Ab) Precedes Development of GAD65Ab and Type 1 Diabetes
por: Larsson, Helena Elding, et al.
Publicado: (2013)

An Interferon-Induced Helicase (IFIH1) Gene Polymorphism Associates With Different Rates of Progression From Autoimmunity to Type 1 Diabetes
por: Winkler, Christiane, et al.
Publicado: (2011)

A public health antibody screening indicates a marked increase of SARS-CoV-2 exposure rate in children during the second wave
por: Hippich, Markus, et al.
Publicado: (2021)

GAD65 Autoantibody Responses in Japanese Latent Autoimmune Diabetes in Adult Patients
por: Maruyama, Taro, et al.
Publicado: (2008)

Bivalent GAD autoantibody ELISA improves clinical utility and risk prediction for adult autoimmune diabetes
por: Kawasaki, Eiji, et al.
Publicado: (2023)

The countdown to type 1 diabetes: when, how and why does the clock start?
por: Ziegler, Anette-Gabriele
Publicado: (2023)

Evidence That HLA Class I and II Associations With Type 1 Diabetes, Autoantibodies to GAD and Autoantibodies to IA-2, Are Distinct
por: Howson, Joanna M.M., et al.
Publicado: (2011)

Detection of Antibodies Directed to the N-Terminal Region of GAD Is Dependent on Assay Format and Contributes to Differences in the Specificity of GAD Autoantibody Assays for Type 1 Diabetes
por: Williams, Alistair J.K., et al.
Publicado: (2015)

BMI at Age 8 Years Is Influenced by the Type 2 Diabetes Susceptibility Genes HHEX-IDE and CDKAL1
por: Winkler, Christiane, et al.
Publicado: (2010)

GAD65 Autoantibodies Detected by Electrochemiluminescence Assay Identify High Risk for Type 1 Diabetes
por: Miao, Dongmei, et al.
Publicado: (2013)

Impact of GAD65 and IA2 autoantibodies on islet allograft survival
por: Lemos, Joana R. N., et al.
Publicado: (2023)

Anti-Idiotypic Antibody Specific to GAD65 Autoantibody Prevents Type 1 Diabetes in the NOD Mouse
por: Wang, Xin, et al.
Publicado: (2012)

ELISA Test for Analyzing of Incidence of Type 1 Diabetes Autoantibodies (GAD and IA2) in Children and Adolescents
por: Delic-Sarac, Marina, et al.
Publicado: (2016)

Comparison of Radioimmunoprecipitation With Luciferase Immunoprecipitation for Autoantibodies to GAD65 and IA-2β
por: Burbelo, Peter D., et al.
Publicado: (2010)

Cesarean Section and Interferon-Induced Helicase Gene Polymorphisms Combine to Increase Childhood Type 1 Diabetes Risk
por: Bonifacio, Ezio, et al.
Publicado: (2011)

Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes
por: Gu, Yong, et al.
Publicado: (2021)

Primary Dietary Intervention Study to Reduce the Risk of Islet Autoimmunity in Children at Increased Risk for Type 1 Diabetes: The BABYDIET study
por: Hummel, Sandra, et al.
Publicado: (2011)

Differential HLA Association of GAD65 and IA2 Autoantibodies in North Indian Type 1 Diabetes Patients
por: Chuzho, Neihenuo, et al.
Publicado: (2021)

GAD65 autoantibodies and glucose tolerance in offspring born to women with and without type 1 diabetes (The EPICOM study)
por: Knorr, Sine, et al.
Publicado: (2021)

Concentration and Activity of the Soluble Form of the Interleukin-7 Receptor α in Type 1 Diabetes Identifies an Interplay Between Hyperglycemia and Immune Function
por: Monti, Paolo, et al.
Publicado: (2013)

Age of Islet Autoantibody Appearance and Mean Levels of Insulin, but Not GAD or IA-2 Autoantibodies, Predict Age of Diagnosis of Type 1 Diabetes: Diabetes Autoimmunity Study in the Young
por: Steck, Andrea K., et al.
Publicado: (2011)

Catatonic Schizophrenia Associated With Cerebrospinal GAD65 Autoantibodies: Case Report and Literature Review
por: Hansen, Niels, et al.
Publicado: (2022)

A Longitudinal Study of GAD65 and ICA512 Autoantibodies During the Progression to Type 1 Diabetes in Diabetes Prevention Trial–Type 1 (DPT-1) Participants
por: Sosenko, Jay M., et al.
Publicado: (2011)

Anti-GAD65 autoantibody levels measured by ELISA and alternative types of immunoassays in relation to neuropsychiatric diseases versus diabetes mellitus type 1
por: Zong, Shenghua, et al.
Publicado: (2023)

Good MRI images: to Gad or not to Gad?
por: Steen, Henning, et al.
Publicado: (2007)

Autoantibodies to N-terminally Truncated GAD(65)(96-585): HLA Associations and Predictive Value for Type 1 Diabetes
por: Pöllänen, Petra M, et al.
Publicado: (2021)

Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening
por: Weiss, Andreas, et al.
Publicado: (2022)

Temporal lobe epilepsy associated with GAD autoimmunity
por: Obata, Atsushi, et al.
Publicado: (2016)

Functional and metabolic fitness of human CD4(+) T lymphocytes during metabolic stress
por: Holthaus, Lisa, et al.
Publicado: (2021)

Correction to: Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening
por: Weiss, Andreas, et al.
Publicado: (2022)

Clinical and Genetic Characteristics of Non-Insulin-Requiring Glutamic Acid Decarboxylase (GAD) Autoantibody-Positive Diabetes: A Nationwide Survey in Japan
por: Yasui, Junichi, et al.
Publicado: (2016)

Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children
por: Lamichhane, Santosh, et al.
Publicado: (2023)

A genome-wide association study in autoimmune neurological syndromes with anti-GAD65 autoantibodies
por: Strippel, Christine, et al.
Publicado: (2022)

No Effect of the 1α,25-Dihydroxyvitamin D(3) on β-Cell Residual Function and Insulin Requirement in Adults With New-Onset Type 1 Diabetes
por: Walter, Markus, et al.
Publicado: (2010)

Presence of Type 1 Diabetes-Related Autoantibodies in Pediatric Population in Bosnia and Herzegovina
por: Zecevic-Pasic, Lamija, et al.
Publicado: (2023)

Immunization against GAD Induces Antibody Binding to GAD-Independent Antigens and Brainstem GABAergic Neuronal Loss
por: Chang, Thashi, et al.
Publicado: (2013)

Zinc Transporter 8 Antibodies Complement GAD and IA-2 Antibodies in the Identification and Characterization of Adult-Onset Autoimmune Diabetes: Non Insulin Requiring Autoimmune Diabetes (NIRAD) 4
por: Lampasona, Vito, et al.
Publicado: (2010)

Cannot write session to /tmp/vufind_sessions/sess_qbvlhvuveadip7d91hb0uqokg2